NCT04137198 is a Phase 4 clinical trial of Sufentanil in Emergencies, sponsored by Centre Hospitalier Universitaire Saint Pierre.

Who is sponsoring NCT04137198?

NCT04137198 is sponsored by Centre Hospitalier Universitaire Saint Pierre.

What drugs are being tested in NCT04137198?

Interventions in NCT04137198: Sufentanil.

What condition does NCT04137198 study?

NCT04137198 studies Emergencies, Pain, Acute, Analgesia, Sufentanil.

Is NCT04137198 still recruiting?

NCT04137198 is currently status unknown. Last updated 5 February 2021.

Last reviewed 2021-02-05 · How we verify

NCT04137198

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sufentanil Intranasal

Status unknown Phase 4 Last updated 5 February 2021

What this trial tests

Phase 4 trial testing Sufentanil in Emergencies in 170 participants. Status unknown.

Timeline

22 January 2020

Primary endpoint
30 July 2025

1 September 2025

Quick facts

Lead sponsor	Centre Hospitalier Universitaire Saint Pierre
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	170
Start date	22 January 2020
Primary completion	30 July 2025
Estimated completion	1 September 2025
Sites	1 location across Belgium

Drugs / interventions tested

Sufentanil (SUFENTANIL) — full drug profile →

Conditions studied

Emergencies — all drugs for Emergencies →
Pain, Acute — all drugs for Pain, Acute →
Analgesia — all drugs for Analgesia →
Sufentanil — all drugs for Sufentanil →

Sponsor

Centre Hospitalier Universitaire Saint Pierre

Who can join

18 and older, any sex, with Emergencies or Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study of the effects of intranasal sufentanil on patients presenting to the emergency department with acute post-traumatic pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of intranasal sufentanil on acute post-traumatic pain in the emergency department: a randomised controlled trial.
Malinverni S, Kreps B, Lucaccioni T, Bouazza FZ, et al · · 2024 · cited 2× · PMID 37770120 · DOI 10.1136/emermed-2023-213353

Verify or expand the search:

Other trials of Sufentanil

Trials testing the same drug.

NCT07386626 — Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection · NA · recruiting
NCT07479446 — Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery · NA · not yet recruiting
NCT07323043 — Comparison of Cough Response Between Tegilidine and Sufentanil as Pre-induction Agents in General Anesthesia · NA · recruiting
NCT07018375 — The Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Th · Phase 4 · not yet recruiting
NCT07376577 — Efficacy and Safety of Anricofen Combined With Ciprofol for Deep Sedation in Elderly Patients Undergoing ERCP · NA · not yet recruiting

Other recruiting trials for Emergencies

Currently open trials in the same condition.

NCT06565390 — Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization · NA · recruiting
NCT07051668 — The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls · NA · recruiting
NCT06680778 — Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch · recruiting
NCT07008391 — High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS · NA · recruiting
NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting

Other Centre Hospitalier Universitaire Saint Pierre trials

Trials by the same sponsor.

NCT06814600 — Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients · recruiting
NCT06214312 — Pulmonary Ultrasound for the Assessment of Atelectasis in Anesthetized Children Using a Laryngeal Mask Airway. · completed
NCT05856396 — Maternal Determinants of Infant Immunity to Pertussis · Phase 4 · completed
NCT05898737 — Nociception Level Index (NOL Index) for Obstetrical Pain Assessment Under Epidural Analgesia. · unknown
NCT05848531 — Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient · Phase 4 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04137198 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Saint Pierre
Last refreshed: 5 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04137198.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing